Tylenol manufacturer Kenvue Brands LLC sent a letter to the Food and Drug Administration, criticizing demands that the drug's label be changed to reflect greater safety warnings.
The FDA announced the first round of pharmaceuticals that will receive expedited reviews under the Commissioner’s National Priority Voucher (CNPV) pilot program.
President Donald Trump announced Thursday from the Oval Office that his administration has secured a deal with pharmaceutical company EMD Serono to cut the cost of key fertility drugs used in in vitro fertilization (IVF) treatments.